-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Tonix Pharmaceuticals Holding Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Tonix Pharmaceuticals Holding Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14.2M, a 49.2% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$135M, a 11.8% decline year-over-year.
- Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$117M, a 5.84% decline from 2022.
- Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$110M, a 19.4% decline from 2021.
- Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$92.3M, a 82.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)